• Title/Summary/Keyword: 카바마제핀

Search Result 5, Processing Time 0.016 seconds

The Effects of Chronic Carbamazepine Administration on Protein Kinase A and Protein Kinase C Activities in Rat Brain (카바마제핀 장기 투여가 백서(白鼠) 뇌의 Protein Kinase A와 Protein Kinase C 활성도에 미치는 영향)

  • Rheem, Doo-Won;Kim, Leen;Suh, Kwang-Yoon
    • Korean Journal of Biological Psychiatry
    • /
    • v.5 no.2
    • /
    • pp.227-234
    • /
    • 1998
  • Objective : Many evidences suggest that patients with bipolar disorder have functional abnormalities in their postreceptor signal transduction pathways, and mood stabilizing effect of lithium is exerted by modulating this dysfunctioning system. Carbamazepine, an antiepileptic agent, is also known to be effective in the treatment and prevention of bipolar disorder. But the precise mechanism of action of the drug is still poorly understood. This study was performed to elucidate the possible therapeutic mechanism of carbamazepine. Method : The effects of chronic carbamazepine administration on protein kinase A and protein kinase C activities in frontal cortex of rat brain after 2 weeks of drug administration were measured and compared with those of control subjects. Results : Mean(${\pm}SE$) value of activity(phosphate transfer ${\mu}mol/mg$ of $protein{\cdot}min$) of protein kinase A in control and test group was $0.249563{\pm}0.036$ and $0.539853{\pm}0.078$, and that of protein kinase C was $0.654817{\pm}0.053$ and $1.146205{\pm}0.052$ respectively, being increased in test group. And differences between the two groups were statistically significant for both enzymes(protein kinase A ; p<0.01, protein kinase C ; p<0.001). Conclusion : These results show that chronic carbamazepine administration increases protein kinase A and C activities, and concerning the possible mode of therapeutic action in bipolar disorder it is suggested that enhanced enzymes phosphorylate receptor-G-protein-effector complexes to dampen hyperfunctioning neuronal activity and thus stabilize the system.

  • PDF

Teratogenic Effect of Carbamazepine (카바마제핀의 기형발생 효과)

  • Choi, Yeong-Tae;Cheon, Jin-Sook
    • Korean Journal of Biological Psychiatry
    • /
    • v.5 no.2
    • /
    • pp.283-287
    • /
    • 1998
  • The mother was 24 years old, primipara, and had been taking carbamazepine 400mg(serum concentration $5.0-8.5{\mu}g/ml$) during pregnancy without any clinical seizures. A male baby with physical malformation was delivered on week 39. The malformation is extradigit(polydactily) on X-ray of right foot and left mild hydronephrosis on ultrasonography and renal scan with radioactive material. We reported this rare case and reviewed related articles about teratogenic effect of carbamazepine, mechanism of action and prevention of teratogenesis.

  • PDF

Effect of Particle Size of HPMC on Dissolution Rate of Venlafaxine HCl and Carbamazepine Sustained Release Tablet (HPMC의 입도에 따른 염산벤라팍신 및 카바마제핀 서방성 정제의 용출 특성)

  • Cha, Jae-Uk;Cha, Ja-Hyun;Hong, Jun-Kee;Lee, Sung-Wan;Ko, Won-Hwa;Beak, Hyun-Ho
    • Polymer(Korea)
    • /
    • v.36 no.3
    • /
    • pp.332-337
    • /
    • 2012
  • The primary objective of this work is to find the properties of sustained release dissolution pattern depending on solubility of drugs, so venlafaxine HCl and carbamazepine tablets were made by using polymer wich various particle size. Hydroxy propyl methyl cellulose (HPMC) has been utilized in this study as an excipient that is one of the most widely used polymers for an oral sustained release formulation, and drug release pattern was strongly influenced by swelling rate depending on particle size of HPMC. Scanning electron microscope (SEM) was employed to investigate the surface of tablets with various HPMC particle size, and differential scanning calorimeter (DSC) was employed to investigate the crystallization of drugs in tablets. The release model equation was applied to analyze the main mechanism of drug release pattern. The results demonstrate that drug release pattern is controlled by the drug solubility and HPMC particle size.

DRUG THERAPY FOR DEVELOPMENTAL DISORDER PATIENTS WITH SELF-MUTILATION (자해 증상을 가진 발달장애아의 약물치료)

  • Kim, Bong-Seog
    • Journal of the Korean Academy of Child and Adolescent Psychiatry
    • /
    • v.14 no.1
    • /
    • pp.53-63
    • /
    • 2003
  • The autistic disorder is identified as an independent clinical entity, since the first description of Leo Kanner. The etiologies of the autistic disorder are almost unclear and the autistic disorder has several abnormalities in aspect of morphology and function of brain. Self-mutilation is observed in the low functioning autistic patients, and early treatment for self mutilation are needed in order not to be chronic. This article reviewed the drugs for the several symptoms of the autistic disorder, especially for self-mutilation. The serotonin reuptake inhibitors does not have clear primary anti-aggressive effects. The dopamine blockers have considerable effects in order to decrease aggression and self injury, and the risperidone is most recommended because of side effects of conventional drugs. The naltrextone does not have consistent study results yet. The clonidine has aggression-decreasing effect. Also lithium is effective on the treatment for aggressive and self-injurious behaviors. And the anticonvulsants including carbamazepine are effective on aggressive explosive behaviors. In the future the pharmacotherapy for self-mutilation will be advanced through stalbe diagnosis and measurement of treatment response.

  • PDF

Characterization of Carbamazepine-Imprinted Acorn Starch/PVA-Based Biomaterials (카바마제핀 각인 도토리 전분/PVA 기반 바이오소재의 특성)

  • Kyeong-Jung Kim;Ji-Hoon Kang;Bo-Gyeong Kim;Min‑Jin Hwang;Soon-Do Yoon
    • Applied Chemistry for Engineering
    • /
    • v.35 no.3
    • /
    • pp.192-199
    • /
    • 2024
  • In this study, carbamazepine (CBZ) imprinted starch/PVA-based biomaterials were prepared by the casting method and UV irradiation, and their physicochemical properties, CBZ adsorption ability, and release properties were investigated. The surface properties of the prepared biomaterials were characterized using FE-SEM, while the stability of CBZ under UV irradiation and the functional groups of the biomaterials were characterized using FT-IR analysis. The adsorption properties of CBZ on the biomaterials were evaluated by binding isotherm and Scatchard plot. Results indicate that CBZ imprinted biomaterials possess a specific binding site of CBZ. To evaluate the applicability of the transdermal drug delivery system, the release properties of CBZ from prepared biomaterials using various pH buffers and artificial skin at 36.5 ℃ were investigated. Results indicated that the CBZ release at high pH was faster than at low pH. In addition, CBZ was released continuously for 12 h in the artificial skin test. The drug release mechanism of CBZ followed a pseudo-Fickian diffusion mechanism in buffer solution, whereas the release from artificial skin exhibited a non-Fickian diffusion mechanism.